Octavus Consulting- Evidence-Based Consulting Services.

Call us: +91 120 428 0707

Clinical Trial Analysis

Case Details

Start Day: 03/10/2024

Clients: Large Biopharma

Tags: Anti-pdx, PD-1 Inhibitors, PD-L1 Inhibitors, Immuno-oncology Trials, Clinical Trial Analytics, Global Clinical Trials, Recruitment Analysis, Patient Recruitment Strategy, Trial Site Selection, Competitive Trial Landscape, Clinical Trial Dashboards, Power BI For Pharma, Trial Registry Analysis, CT.Gov Analysis, Eudract Insights, China Clinical Trials, JAPANCT Data, WHO Trial Registry, Oncology R&D, Biomarker-driven Trials, Drug Development Strategy, Clinical Operations Optimization, Trial Feasibility, Pharma Data Analytics

Project Duration: 12 Months

Let’s Work Together for Development

Call us directly, submit a sample or email us!

Business Address
First Floor, B-66, Sector 63,
Noida, UP, India-201301
Connect With Us
Call us: +91 120 428 0707
bd@octavusconsulting.com
Working Hours
Mon - Fri: 10.00 AM - 07.00 PM
Holidays : Closed

The Story

Clinical trial and recruitment analysis for all the anti-PDx molecules across indications

Compiled data of anti-PDx molecules clinical trials from global registries and created a database using the Power BI dashboard by conducting a thorough analysis facilitating the client’s selection of global trial locations with minimized competition and optimized recruitment processes. 

What Did Octavus Do

The analysis facilitated our client’s selection of a global location with reduced competition for recruitment and streamlined recruitment processes during trials.

Data Analysis Chart

Clinical Trial Analysis 

The Results

Octavus proposed these solutions based on the research conducted for Client.

Created a curated database for the clinical trials for all the anti-PDx molecules
Created a Power BI dashboard for all the clinical trials of all anti-PDx molecules. These can be updated on weekly basis
Conducted a thorough, exhaustive clinical trial summarization and recruitment analysis of for all the anti-PDx molecules for all indications